Diabetes mellitus is a metabolic disease that leads to several complications which include retinopathy. Neuronal abnormalities have been reported to appear before microvasculature alterations. We analyzed the expression levels of GlyR subunits in the retina at 7, 20, and 45 days after streptozotocin-induced diabetes to gain insight into the pathogenesis of diabetic retinopathy. We determined the mRNA and protein expression by qPCR and western blot, respectively. The mRNA and protein expression of the α1 subunit was not altered over the study period; however, they were slightly reduced in α2 yet statistically significant. While protein expression of α3 subunit was only reduced at 45 days diabetes. The mRNA and protein expression of the α4 subunit was remarkably decreased since day 7 of diabetes, remaining only ∼20% on day 45 of diabetes. Surprisingly, the mRNA of the β subunit was highly increased, while its protein levels were not changed. The decrease in GlyR α subunits expression in the retina from diabetic animals suggest a perturbation in the inhibitory glycine signaling pathway, which might be related to the visual alterations observed in diabetes.
Introduction
Diabetic retinopathy is one of the most common complications of diabetes mellitus and it causes blindness in working-age adults [1] . Diabetic retinopathy usually refers to vascular abnormalities, but increasing evidence indicates the occurrence of neural alterations which precedes the microvascular pathology observed at later stages of the disease [2] [3] [4] . Abnormalities in oscillatory potentials and b waves of the electroretinogram, as well as in contrast sensitivity have been reported in diabetic patients and rodents [5] [6] [7] [8] [9] [10] ; in spite of this information, the underlying neural mechanisms involved are largely unknown.
Retina excitatory neurotransmission is modulated by glycine and GABA, the major inhibitory neurotransmitters in retina, localized in different types of amacrine cells, which carry out specific roles in the processing of visual signals [11] . Around 50% of the amacrine cells are glycinergic, which make synaptic contacts with bipolar, ganglion, and other amacrine cells [12, 13] .
The postsynaptic glycine receptors (GlyR) are pentameric ligandgated chloride channel composed by α (1) (2) (3) (4) and β subunits, assembled as homomeric (α subunits) or heteromeric (α-β subunits) receptors [14] . The β subunit is considered essential for clustering GlyR at synapses due to its direct interaction with the cytoplasmic clustering protein gephyrin [15] . All five subunits are expressed in the inner plexiform layer of the adult mammalian retina [16] [17] [18] and their characteristic distribution across the inner plexiform layer and neuronal subtype localization suggests they are involved with different neuronal circuits [13] . Therefore, the aim of the present study was to investigate whether changes on glycine receptor subunits expression occur in the retina at early diabetes induction in the rat. 
Animals
Female adult Long Evans rats (180-200 g) were used for the experiments. Diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ) (90 mg/kg) [19] . No insulin was administered. Animals were considered diabetic if blood glucose levels were higher than 250 mg/dl. Rats were sacrificed after 7, 20, and 45 days after diabetes induction, along with non-treated animals (normal). Blood was collected and the eyes dissected. Eyes were equatorial sectioned and the retinas were shed away from the eye cups using fine pincers.
This study was carried out in strict accordance with the recommendations of the Mexican Institutes of Health Research (DOF. NOM-062-Z00-1999). The protocol was approved by our Institutional Laboratory Animal Care and Use Committee (CICUAL, in Spanish, Comité Institucional para el Cuidado y Uso de los Animales de Laboratorio del Instituto de Fisiología Celular de la Universidad Nacional Autónoma de México), Protocol Number RSS18-14; this was done in accordance with the Office of Laboratory Animal Welfare (OLAW), Assurance Number A5281-01.
All efforts were made to minimize animal suffering and to reduce the number of rats employed.
RNA extraction
Total retina RNA was extracted with TRIZOL and cDNA was synthesized with the RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific) following the manufacturer instructions. RNA integrity and concentration was verified by spectrophotometry (NanoDrop1000, Thermo Scientific) and 2% agarose gels.
Quantitative real-time PCR
Absolute quantification of mRNA was performed according to the method described by Pffafl [20] . A standard curve was constructed from serial dilutions (51, 0.51, 0.0051, 0.000051, and 0.00000051 pg) of the purified 18S (18S ribosomal RNA) gene and it was run with each GlyR subunit: α1-α4 or β. PCR conditions were: holding stage (50°C (2 min); 95°C (2 min); forty cycles (95°C, 15 s); TM (1 min); Melt curve (95°C, 15 s); 60°C (1 min); 72°C (1 min). Primers were designed with the Primer 3 tool (Koressaar and Remm, 2007; Untergasser et al., 2012) and purchased from Oligo T4 (Guanajuato, Gto. Mexico). 18S (TM=75.6°C): Forward: Reverse: α1 (TM = 63.4°C) Forward: 5´-ACTCTGCGATTCTACCTTTGG-3´, Reverse:
The α4 subunit was amplified by using the Prime® qPCR Primers (Rn.PT.56a. 12226027; Exon location 7e8) from Integrated DNA Technologies (Coralville, IA, USA) Time Agarose gels (2%) were run to corroborate the specific amplification.
Western blotting
Retinas were homogenized in RIPA buffer (50 mM Tris-HCl pH 7.2, 150 mM NaCl, 2% triton X-100, 0.2% SDS) containing proteases and phosphatases inhibitors. Proteins were resolved through 10% SDS-PAGE and electro blotted to immobilon membranes. The membranes were blocked for 3 h in 5% no-fat milk, and incubated overnight at 4°C with the primary antibodies prepared in Bovine serum albumin 5%: Rabbit anti-α1, 1:3000 (Synaptic Systems); rabbit anti-α2, 1:3000 (abcam); rabbit anti-α3, 1:1000 (abcam); rabbit anti-α4, 1:3000 (Biorbyt); rabbit anti-β, 1:2000 (abcam). After washing thoroughly, the membranes were incubated with the corresponding horseradish peroxidase-conjugated secondary antibodies (Amersham ECL Anti-Rabbit-HRP 1:45,000 for anti-α1; 1:30,000 for anti-α2, anti-α3, anti-α4 and 1:15,000 for anti-β).
The immunoreactive bands were visualized using a Chemiluminescent HRP Substrate (Immobilon Western Chemiluminescent HRP Substrate, Millipore Corp.) according to the manufacturer's instructions. Western blot densitometric analysis was normalized to the amount of actin, using a mouse monoclonal anti panactin 1:2000 (abcam) and Anti-Mouse-HRP 1:15,000 (Amersham). Densitometric images and data obtained with Alpha DigiDoc RT (Alpha Innotech, San Leandro, CA) were analyzed using Graph Pad Prism5 software (San Diego, CA, USA).
Statistical analysis
Data are expressed as the mean ± SEM. Statistical significance was determined by one way ANOVA analysis followed by Tukey´s test multiple comparison using Graph Pad Prisma 5. Statistical significance was assumed at P ≤ 0.05.
Results

Metabolic state of streptozotocin-treated rats
The existence of diabetes in streptozotocin treated rats was inferred from hyperglycemia, impaired growth, polydipsia and polyuria (Table 1) 
qPCR studies
mRNA GlyR subunits (α1-α4 and β) were evaluated by qPCR. Expression of all subunits was found in the normal rat retina, where the predominant subunits were α2 (5.7 ± 0.15 pg) and α1 (3.14 ± 0.85 pg), followed by α3 (1.33 ± 0.86 pg) and α4 (1.0 ± 0.07 pg); the β subunit showed high expression levels (5.0 ± 0.4 pg) [21] . The relative changes of each GlyR subunit mRNA in the diabetic stage are shown in Fig. 1 . The α1 and α3 mRNA expression was not statistically significant over the diabetes study period (Fig. 1) . Bizarrely, levels of α3 mRNA expression were founds significantly higher at 20-days of diabetes. On the contrary, the expression of the α2 mRNA expression showed a considerable reduction (30%) from 7 days after STZ administration ( Fig. 1) . Meanwhile, the α4 mRNA expression displayed a prominent and continuous decrease from day 7 of diabetes, showing values almost undetectable on day 45 of the STZ treatment. Regarding the β subunit mRNA expression values, these were remarkably increased (∼2 folds) from early stages of diabetes ( Fig. 1 ).
Western blotting studies
Western blot for normal rat retina revealed a band of 48-51 kDa for Values are the mean ± SEM of 7-12 animals per group. Glucose blood levels of normal (control) rats were 114 ± 4 mg/dl. Water intake in 12 h by normal rats was 33 ± 3 ml. *P < 0.01 compared to normal non streptozotocin treated rats. all α subunits. The α1 and α2 subunits showed the higher expression, followed by the α3 and α4 (not shown), as previously reported [21] . Similar to that observed at mRNA level, the α1 GlyR subunit did not show expression changes under diabetic conditions ( Fig. 2A) , while the expression of the other α subunits was significantly reduced. The α2 subunit modestly decreased (20-30 %) at 20-and 45-days of diabetes (Fig. 2B) , and the α3 subunit showed a considerable decrease (34%) at 45 days (Fig. 2C) . Interestingly, the α4 subunit expression significantly decreased (25%) from day 7 of diabetes induction, remaining only 30% on day 45 of diabetes (Fig. 2D) . Concerning the β subunit, western blot analysis revealed a 48.7 kDa protein band in both normal and diabetic rat retina. In the normal retina, the relative β subunit expression was around 5-6 folds higher than the α2 subunit (not shown). In the diabetic rat retina, the β subunit expression showed a small not significant increase over the period study ( Fig. 2E ).
Discussion
Diabetic retinopathy is clinically diagnosed by the onset of vascular disorders, suggesting that it is solely a microvascular disease [22, 23] . However, early visual defects in diabetes appear to be a result of an impairment of the neural retina [2] [3] [4] . Abnormalities in the electroretinogram components have been reported in humans and rats with diabetes [5, 8, 9, 24, 25] . These alterations are accompanied by deficits in light and color sensitivity in patients at early diabetic retinopathy [6, 7, 10] . In addition, ganglion cell degeneration has been reported in diabetic patients as well as in animal models at long-term diabetes [2, 26] .
The glycinergic amacrine cells are known to generate inhibitory output into bipolar cells, ganglion cells and other amacrine cells. This signaling is essential in regulating the response properties of different classes of retinal ganglion cells [27] [28] [29] . Considerable evidence indicates that glycinergic inhibition modulates light responses of retinal neurons and is also involved in specificity, preferentially by crossover inhibition between the ON-and the OFF-channels. Glycine exerts its action through strychnine-sensitive ionotropic receptors, the GlyR, which open a chloride channel leading to hyperpolarization of the cell. GlyR are formed by α (1-4) subunits and a single β subunit, which are considered to form heteromeric receptors with stoichiometry of 2α/3β subunits [30] . The five subunits have been identified in the mammalian retina where they are expressed in the inner plexiform layer (IPL) [16, 17, 31] . Therefore, we aimed at analyzing whether diabetes influences retinal glycinergic neurotransmission to determine the expression of GlyR subunit isoforms.
We found that both mRNA and protein expression of α1 subunit, which is a main input to light transmitting ganglion cells [32] , was not modified over the diabetes study. However, while the mRNA expression of the retina predominant α2 subunit [21] decreased over the diabetes study period, its protein dropped after 20-45 days of diabetes. It has been demonstrated that GlyRα2 is expressed by bipolar cell axon terminals and amacrine cells, and almost all ganglion cells [17] . Meanwhile, α3 mRNA expression was variable, but protein expression was reduced on the day 45 of the STZ treatment. The α3 subunit is distributed widely throughout the inner plexiform layer; in fact, all amacrine express α3β GlyR [13] . Although slight, the reduction in the expression of these subunits may be relevant, given that there is evidence that GlyRα2 and GlyRα3 inhibition enhance ganglion cells excitatory center responses, and GlyRα2 modulates crossover inhibition in both the ON and OFF pathways. In addition, GlyRα2 crossover and GlyRα3 serial inhibition are additive and independent in the ON retinal pathway.
Noteworthy, both the mRNA and protein expression of the α4 subunit were significantly reduced from very early diabetes stages. The GlyRα4 subunit is localized throughout the inner plexiform layer with highest density in cholinergic amacrine cells (starburst amacrine cells, SAC) [18] , which play key roles in the direction selectivity [33, 34] .
Indeed, pharmacological studies showed that SAC lose direction selectivity in the absence of inhibition [35] . Interesting, decrease of cholinesterase activities were found in STZ-diabetic rats [36] , and death of cholinergic cells in Ins2-Akita mice [37] . Remarkable, double labeling immunohistochemical experiments revealed that approximately 30% of the α4 containing synapses also express α2 subunit [18] . Therefore, our results suggest a decrease in α4-GlyR signaling in SAC and other amacrine and/or ganglion cells.
The β subunit is expressed throughout the IPL, which is expected, since β subunit is required for agonist binding [30] , and all GlyR receptors appear to require the β subunit to target the membrane by means of its linking to gephyrin [15] . Biochemical evidence indicates that the β subunit does not assemble as pentameric homomers [38] ; therefore, its higher mRNA expression must likely suggest changes in its synthesis and /or degradation, which has to be further studied.
Conclusion
We found a decrease in the expression of α4, α3, and α2 GlyR subunits in the rat retina at very early diabetes induction, suggesting alteration in retina glycinergic neurotransmission. 
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